The peroxisome proliferator-activated receptor gamma agonist, pioglitazone (Actos®—a drug used for diabetes), shows protective effects in the brain, delays onset and severity in rodent EAE models [35, 36] and is used as an add-on therapy for RRMS for treatment of nerve pain [37]. This evidence concerns the gene PPARG and diabetes mellitus.